{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T23:29:29Z","timestamp":1786318169232,"version":"build-2736575974"},"reference-count":44,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T00:00:00Z","timestamp":1780012800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,8,10]],"date-time":"2026-08-10T00:00:00Z","timestamp":1786320000000},"content-version":"vor","delay-in-days":73,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"funder":[{"name":"The Myung-Sun Kim Momorial Foundation"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Sci Rep"],"DOI":"10.1038\/s41598-026-55438-4","type":"journal-article","created":{"date-parts":[[2026,5,29]],"date-time":"2026-05-29T08:14:53Z","timestamp":1780042493000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ethnicity-specific molecular subtypes and a machine-learning risk model in Asian patients with non-muscle-invasive bladder cancer"],"prefix":"10.1038","volume":"16","author":[{"given":"Minsun","family":"Jung","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sangyong","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insoon","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dohyun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong Mee","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwangsoo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Chul","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,5,29]]},"reference":[{"key":"55438_CR1","first-page":"209","volume":"71","author":"H Sung","year":"2021","unstructured":"Sung, H. et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J. Clin. 71, 209\u2013249 (2021).","journal-title":"CA Cancer J. Clin."},{"key":"55438_CR2","doi-asserted-by":"publisher","first-page":"628","DOI":"10.1016\/j.euo.2022.10.003","volume":"5","author":"N Lobo","year":"2022","unstructured":"Lobo, N. et al. Epidemiology, screening, and prevention of bladder cancer. Eur. Urol. Oncol. 5, 628\u2013639 (2022).","journal-title":"Eur. Urol. Oncol."},{"key":"55438_CR3","doi-asserted-by":"publisher","first-page":"952","DOI":"10.1016\/j.eururo.2017.05.032","volume":"72","author":"EJ Pietzak","year":"2017","unstructured":"Pietzak, E. J. et al. Next-generation sequencing of nonmuscle invasive bladder cancer reveals potential biomarkers and rational therapeutic targets. Eur. Urol. 72, 952\u2013959 (2017).","journal-title":"Eur. Urol."},{"key":"55438_CR4","doi-asserted-by":"publisher","first-page":"2301","DOI":"10.1038\/s41467-021-22465-w","volume":"12","author":"SV Lindskrog","year":"2021","unstructured":"Lindskrog, S. V. et al. An integrated multi-omics analysis identifies prognostic molecular subtypes of non-muscle-invasive bladder cancer. Nat. Commun. 12, 2301 (2021).","journal-title":"Nat. Commun."},{"key":"55438_CR5","doi-asserted-by":"publisher","first-page":"533","DOI":"10.1016\/j.eururo.2020.06.048","volume":"78","author":"AG Robertson","year":"2020","unstructured":"Robertson, A. G. et al. Identification of differential tumor subtypes of T1 bladder cancer. Eur. Urol. 78, 533\u2013537 (2020).","journal-title":"Eur. Urol."},{"key":"55438_CR6","doi-asserted-by":"publisher","first-page":"4599","DOI":"10.1158\/1078-0432.CCR-21-0205","volume":"27","author":"JS Damrauer","year":"2021","unstructured":"Damrauer, J. S. et al. Identification of a novel inflamed tumor microenvironment signature as a predictive biomarker of Bacillus Calmette-Guerin immunotherapy in non-muscle-invasive bladder cancer. Clin. Cancer Res. 27, 4599\u20134609 (2021).","journal-title":"Clin. Cancer Res."},{"key":"55438_CR7","doi-asserted-by":"publisher","first-page":"410e419","DOI":"10.1016\/j.urolonc.2022.04.013","volume":"40","author":"S You","year":"2022","unstructured":"You, S. et al. Characterizing molecular subtypes of high-risk non-muscle-invasive bladder cancer in African American patients. Urol. Oncol. 40, 410e419\u2013410e427 (2022).","journal-title":"Urol. Oncol."},{"key":"55438_CR8","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1186\/s13008-025-00172-y","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai, H. et al. Integrating genetic crosstalk between atherosclerosis and lung adenocarcinoma to advance precision diagnosis and treatment. Cell. Div. 20, 27 (2025).","journal-title":"Cell. Div."},{"key":"55438_CR9","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1186\/s13062-025-00650-x","volume":"20","author":"H Dai","year":"2025","unstructured":"Dai, H. et al. Integrating machine learning models with multi-omics analysis to decipher the prognostic significance of mitotic catastrophe heterogeneity in bladder cancer. Biol. Direct. 20, 56 (2025).","journal-title":"Biol. Direct"},{"key":"55438_CR10","doi-asserted-by":"publisher","first-page":"229","DOI":"10.1186\/s12894-025-01914-4","volume":"25","author":"H Dai","year":"2025","unstructured":"Dai, H. et al. Machine learning model in multi-omics perspective demystifies the prognostic significance of crotonylation heterogeneity in clear cell renal cell carcinoma. BMC Urol. 25, 229 (2025).","journal-title":"BMC Urol."},{"key":"55438_CR11","doi-asserted-by":"publisher","first-page":"15","DOI":"10.1186\/s12935-025-04133-x","volume":"26","author":"H Dai","year":"2026","unstructured":"Dai, H. et al. Integrating machine learning and multi-omics analysis to explore Treg-associated programmed cell death features in clear cell renal cell carcinoma. Cancer Cell. Int. 26, 15 (2026).","journal-title":"Cancer Cell. Int."},{"key":"55438_CR12","doi-asserted-by":"publisher","first-page":"12","DOI":"10.1038\/ng.3458","volume":"48","author":"MA Castro","year":"2016","unstructured":"Castro, M. A. et al. Regulators of genetic risk of breast cancer identified by integrative network analysis. Nat. Genet. 48, 12\u201321 (2016).","journal-title":"Nat. Genet."},{"key":"55438_CR13","doi-asserted-by":"crossref","unstructured":"Mun, J. Y. et al. E2F1 promotes progression of bladder cancer by modulating RAD54L involved in homologous recombination repair. Int J. Mol. Sci 21 (2020).","DOI":"10.3390\/ijms21239025"},{"key":"55438_CR14","doi-asserted-by":"publisher","first-page":"472","DOI":"10.1016\/j.bbrc.2019.03.207","volume":"513","author":"J Zhang","year":"2019","unstructured":"Zhang, J. et al. Up-regulation of FAM64A promotes epithelial-to-mesenchymal transition and enhances stemness features in breast cancer cells. Biochem. Biophys. Res. Commun. 513, 472\u2013478 (2019).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"55438_CR15","doi-asserted-by":"publisher","first-page":"3737","DOI":"10.1038\/s41598-018-22126-x","volume":"8","author":"NA Marzouka","year":"2018","unstructured":"Marzouka, N. A. et al. A validation and extended description of the Lund taxonomy for urothelial carcinoma using the TCGA cohort. Sci. Rep. 8, 3737 (2018).","journal-title":"Sci. Rep."},{"key":"55438_CR16","doi-asserted-by":"publisher","first-page":"152","DOI":"10.1016\/j.ccr.2014.01.009","volume":"25","author":"W Choi","year":"2014","unstructured":"Choi, W. et al. Identification of distinct basal and luminal subtypes of muscle-invasive bladder cancer with different sensitivities to frontline chemotherapy. Cancer Cell. 25, 152\u2013165 (2014).","journal-title":"Cancer Cell."},{"key":"55438_CR17","doi-asserted-by":"publisher","first-page":"420","DOI":"10.1016\/j.eururo.2019.09.006","volume":"77","author":"A Kamoun","year":"2020","unstructured":"Kamoun, A. et al. A consensus molecular classification of muscle-invasive bladder cancer. Eur. Urol. 77, 420\u2013433 (2020).","journal-title":"Eur. Urol."},{"key":"55438_CR18","doi-asserted-by":"publisher","first-page":"448","DOI":"10.1093\/jnci\/djx243","volume":"110","author":"Q Mo","year":"2018","unstructured":"Mo, Q. et al. Prognostic power of a tumor differentiation gene signature for bladder urothelial carcinomas. J. Natl. Cancer Inst. 110, 448\u2013459 (2018).","journal-title":"J. Natl. Cancer Inst."},{"key":"55438_CR19","doi-asserted-by":"publisher","first-page":"540","DOI":"10.1016\/j.cell.2017.09.007","volume":"171","author":"AG Robertson","year":"2017","unstructured":"Robertson, A. G. et al. Comprehensive molecular characterization of muscle-invasive bladder cancer. Cell 171, 540\u2013556e525 (2017).","journal-title":"Cell"},{"key":"55438_CR20","doi-asserted-by":"publisher","first-page":"1235","DOI":"10.1016\/j.celrep.2014.10.035","volume":"9","author":"A Biton","year":"2014","unstructured":"Biton, A. et al. Independent component analysis uncovers the landscape of the bladder tumor transcriptome and reveals insights into luminal and basal subtypes. Cell. Rep. 9, 1235\u20131245 (2014).","journal-title":"Cell. Rep."},{"key":"55438_CR21","doi-asserted-by":"publisher","first-page":"3110","DOI":"10.1073\/pnas.1318376111","volume":"111","author":"JS Damrauer","year":"2014","unstructured":"Damrauer, J. S. et al. Intrinsic subtypes of high-grade bladder cancer reflect the hallmarks of breast cancer biology. Proc. Natl. Acad. Sci. U S A. 111, 3110\u20133115 (2014).","journal-title":"Proc. Natl. Acad. Sci. U S A"},{"key":"55438_CR22","doi-asserted-by":"publisher","first-page":"2636","DOI":"10.1002\/ijc.32737","volume":"146","author":"G Sjodahl","year":"2020","unstructured":"Sjodahl, G. et al. Molecular changes during progression from nonmuscle invasive to advanced urothelial carcinoma. Int. J. Cancer. 146, 2636\u20132647 (2020).","journal-title":"Int. J. Cancer"},{"key":"55438_CR23","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1016\/j.immuni.2018.03.023","volume":"48","author":"V Thorsson","year":"2018","unstructured":"Thorsson, V. et al. The immune landscape of cancer. Immunity 48, 812\u2013830e814 (2018).","journal-title":"Immunity"},{"key":"55438_CR24","doi-asserted-by":"publisher","first-page":"12521","DOI":"10.1038\/s41598-018-29987-2","volume":"8","author":"Y Wang","year":"2018","unstructured":"Wang, Y., Chang, Q. & Li, Y. Racial differences in Urinary Bladder Cancer in the United States. Sci. Rep. 8, 12521 (2018).","journal-title":"Sci. Rep."},{"key":"55438_CR25","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1186\/s41065-025-00409-4","volume":"162","author":"H Dai","year":"2025","unstructured":"Dai, H. et al. ADME gene-driven prognostic model for bladder cancer: a breakthrough in predicting survival and personalized treatment. Hereditas 162, 42 (2025).","journal-title":"Hereditas"},{"key":"55438_CR26","doi-asserted-by":"publisher","first-page":"e910","DOI":"10.1093\/oncolo\/oyad120","volume":"28","author":"T Peak","year":"2023","unstructured":"Peak, T. et al. Comparative genomic landscape of urothelial carcinoma of the bladder among patients of east and south Asian genomic ancestry. Oncologist 28, e910\u2013e920 (2023).","journal-title":"Oncologist"},{"issue":"Suppl 1","key":"55438_CR27","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1186\/1476-069X-11-S1-S11","volume":"11","author":"S Letasiova","year":"2012","unstructured":"Letasiova, S. et al. Bladder cancer, a review of the environmental risk factors. Environ. Health. 11 (Suppl 1), S11 (2012).","journal-title":"Environ. Health"},{"key":"55438_CR28","doi-asserted-by":"publisher","first-page":"e16","DOI":"10.1634\/theoncologist.2019-0123","volume":"25","author":"CH Chen","year":"2020","unstructured":"Chen, C. H. et al. Disparity in tumor immune microenvironment of breast cancer and prognostic impact: Asian versus Western populations. Oncologist 25, e16\u2013e23 (2020).","journal-title":"Oncologist"},{"key":"55438_CR29","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/s41389-023-00489-9","volume":"12","author":"B Doshi","year":"2023","unstructured":"Doshi, B., Athans, S. R. & Woloszynska, A. Biological differences underlying sex and gender disparities in bladder cancer: current synopsis and future directions. Oncogenesis 12, 44 (2023).","journal-title":"Oncogenesis"},{"key":"55438_CR30","doi-asserted-by":"crossref","unstructured":"Poisa-Beiro, L. et al. Accumulation of lymphoid progenitors with defective B cell differentiation and of putative natural killer progenitors in aging human bone marrow. Int J. Mol. Sci 26 (2025).","DOI":"10.3390\/ijms262110467"},{"key":"55438_CR31","doi-asserted-by":"publisher","first-page":"15235","DOI":"10.2147\/IJN.S557690","volume":"20","author":"J Chen","year":"2025","unstructured":"Chen, J. et al. Nanomaterial-enhanced immunotherapy: advancing T-cell-based treatments for bladder cancer. Int. J. Nanomed. 20, 15235\u201315275 (2025).","journal-title":"Int. J. Nanomed."},{"key":"55438_CR32","doi-asserted-by":"publisher","first-page":"1320","DOI":"10.1158\/2326-6066.CIR-23-1114","volume":"12","author":"P Yolmo","year":"2024","unstructured":"Yolmo, P. et al. Atypical B cells promote cancer progression and poor pesponse to bacillus Calmette-Guerin in non-muscle invasive bladder cancer. Cancer Immunol. Res. 12, 1320\u20131339 (2024).","journal-title":"Cancer Immunol. Res."},{"key":"55438_CR33","first-page":"284","volume":"6","author":"EM Garcia-Cuesta","year":"2015","unstructured":"Garcia-Cuesta, E. M. et al. NKG2D is a key receptor for recognition of bladder cancer cells by IL-2-activated NK cells and BCG Promotes NK cell activation. Front. Immunol. 6, 284 (2015).","journal-title":"Front. Immunol."},{"key":"55438_CR34","doi-asserted-by":"publisher","first-page":"110","DOI":"10.1016\/j.eururo.2024.09.012","volume":"87","author":"R Li","year":"2025","unstructured":"Li, R. et al. FGFR inhibition in urothelial carcinoma. Eur. Urol. 87, 110\u2013122 (2025).","journal-title":"Eur. Urol."},{"key":"55438_CR35","doi-asserted-by":"publisher","first-page":"390","DOI":"10.1158\/1078-0432.CCR-18-0685","volume":"25","author":"C Rubio","year":"2019","unstructured":"Rubio, C. et al. CDK4\/6 inhibitor as a novel therapeutic approach for advanced bladder cancer Independently of RB1 status. Clin. Cancer Res. 25, 390\u2013402 (2019).","journal-title":"Clin. Cancer Res."},{"key":"55438_CR36","doi-asserted-by":"crossref","unstructured":"Jung, M., Jang, I., Kim, K. & Moon, K. C. Non-muscle-invasive bladder carcinoma with respect to basal versus luminal keratin expression. Int J. Mol. Sci 21 (2020).","DOI":"10.3390\/ijms21207726"},{"key":"55438_CR37","doi-asserted-by":"publisher","first-page":"273","DOI":"10.1177\/1947601913501074","volume":"4","author":"VP Muniz","year":"2013","unstructured":"Muniz, V. P. et al. RABL6A promotes oxaliplatin resistance in tumor cells and is a new marker of survival for resected rancreatic ductal adenocarcinoma patients. Genes Cancer. 4, 273\u2013284 (2013).","journal-title":"Genes Cancer"},{"key":"55438_CR38","doi-asserted-by":"publisher","first-page":"e2895","DOI":"10.1038\/cddis.2017.244","volume":"8","author":"J Musa","year":"2017","unstructured":"Musa, J., Aynaud, M. M., Mirabeau, O., Delattre, O. & Grunewald, T. G. MYBL2 (B-Myb): a central regulator of cell proliferation, cell survival and differentiation involved in tumorigenesis. Cell. Death Dis. 8, e2895 (2017).","journal-title":"Cell. Death Dis."},{"key":"55438_CR39","doi-asserted-by":"publisher","first-page":"3734","DOI":"10.1158\/1078-0432.CCR-20-5037","volume":"27","author":"J Borcsok","year":"2021","unstructured":"Borcsok, J. et al. Detection of molecular signatures of homologous recombination deficiency in bladder cancer. Clin. Cancer Res. 27, 3734\u20133743 (2021).","journal-title":"Clin. Cancer Res."},{"key":"55438_CR40","doi-asserted-by":"publisher","first-page":"835","DOI":"10.1007\/s12282-019-00991-2","volume":"26","author":"Z Yao","year":"2019","unstructured":"Yao, Z. et al. Knockdown of FAM64A suppresses proliferation and migration of breast cancer cells. Breast Cancer. 26, 835\u2013845 (2019).","journal-title":"Breast Cancer"},{"key":"55438_CR41","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1186\/1476-4598-9-3","volume":"9","author":"WJ Kim","year":"2010","unstructured":"Kim, W. J. et al. Predictive value of progression-related gene classifier in primary non-muscle invasive bladder cancer. Mol. Cancer. 9, 3 (2010).","journal-title":"Mol. Cancer"},{"key":"55438_CR42","doi-asserted-by":"publisher","first-page":"2660","DOI":"10.1200\/JCO.2009.25.0977","volume":"28","author":"JS Lee","year":"2010","unstructured":"Lee, J. S. et al. Expression signature of E2F1 and its associated genes predict superficial to invasive progression of bladder tumors. J. Clin. Oncol. 28, 2660\u20132667 (2010).","journal-title":"J. Clin. Oncol."},{"key":"55438_CR43","doi-asserted-by":"publisher","first-page":"523","DOI":"10.1093\/bioinformatics\/btt703","volume":"30","author":"A Kramer","year":"2014","unstructured":"Kramer, A., Green, J., Pollard, J. Jr. & Tugendreich, S. Causal analysis approaches in Ingenuity Pathway Analysis. Bioinformatics 30, 523\u2013530 (2014).","journal-title":"Bioinformatics"},{"key":"55438_CR44","doi-asserted-by":"publisher","first-page":"16878","DOI":"10.1038\/s41598-017-17204-5","volume":"7","author":"P Bankhead","year":"2017","unstructured":"Bankhead, P. et al. QuPath: open source software for digital pathology image analysis. Sci. Rep. 7, 16878 (2017).","journal-title":"Sci. Rep."}],"container-title":["Scientific Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55438-4","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55438-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55438-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,9]],"date-time":"2026-08-09T23:10:16Z","timestamp":1786317016000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41598-026-55438-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,29]]},"references-count":44,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["55438"],"URL":"https:\/\/doi.org\/10.1038\/s41598-026-55438-4","relation":{},"ISSN":["2045-2322"],"issn-type":[{"value":"2045-2322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,29]]},"assertion":[{"value":"13 May 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 May 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"29 May 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"The authors declare no competing interests.","order":1,"name":"Ethics","label":"Competing interests","group":{"name":"EthicsHeading","label":"Declarations"}}],"article-number":"24596"}}